Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
1994 •
Molecular Biology of the Cell
Transferrin Receptor 2: Evidence for Ligand-induced Stabilization and Redirection to a Recycling Pathway2007 •
The Journal of Heart and Lung Transplantation
Cardiogenic Shock in Peripartum Cardiomyopathy: How to Succeed without Long-Term Left Ventricular Assist Device? Experience of Argentinean Center2017 •
Marine Biodiversity
A new record of Neobythites multistriatus Nielsen & Quéro, 1991 (Ophidiiformes: Ophidiidae) from the Andaman Sea, North Indian Ocean2016 •
Tetrahedron Letters
Studies of zoanthamine alkaloids. Enantiocontrolled construction of the tetracyclic hemi-aminal core1998 •
World journal of methodology
Synergetic role of integrating the departments of cancer registry and clinical research at an academic comprehensive cancer center2017 •
Asian-Australasian Journal of Animal Sciences
Stimulation of Exocrine Pancreas Secretion by Exogenous CCK-8 and Secretin Boluses during Cold Vagal Blockade1989 •
Cell Biology International
IL‐6 stimulation of DNA replication is JAK1/2 mediated in cross‐talk with hyperactivated ERK1/2 signaling2019 •
Myeloproliferative neoplasms (MPNs) are developing resistance to therapy by JAK1/2 inhibitor ruxolitinib. To explore the mechanism of ruxolitinib's limited effect, we examined the JAK1/2 mediated induction of proliferation related ERK1/2 and AKT signaling by proinflammatory interleukin‐6 (IL‐6) in MPN granulocytes and JAK2V617F mutated human erythroleukemia (HEL) cells. We found that JAK1/2 or JAK2 inhibition prevented the IL‐6 activation of STAT3 and AKT pathways in polycythemia vera and HEL cells. Further, we showed that these inhibitors also blocked the IL‐6 activation of the AKT pathway in primary myelofibrosis (PMF). Only JAK1/2 inhibitor ruxolitinib largely activated ERK1/2 signaling in essential thrombocythemia and PMF (up to 4.6 fold), with a more prominent activation in JAK2V617F positive granulocytes. Regarding a cell cycle, we found that IL‐6 reduction of HEL cells percentage in G2M phase was reversed by ruxolitinib (2.6 fold). Moreover, ruxolitinib potentiated apopto...
American Journal of Neuroradiology
Prenatal Evaluation of Intracranial Hemorrhage on Fetal MRI: A Retrospective Review2021 •
Journal of Biomolecular Structure and Dynamics
A Molecular Dynamics Simulation Study of Coaxial Stacking in RNA2000 •
Acta Anaesthesiologica Scandinavica
Regional venous oxygen saturation versus mixed venous saturation after paediatric cardiac surgery2012 •
International Immunopharmacology
Antioxidant and anti-inflammatory effect of polysaccharides from Lobophora variegata on zymosan-induced arthritis in rats2011 •
2007 •
2021 •
Science Journal of Chemistry
Evaluation of Antioxidant Activities of Celosia trigyna (Linn) Extracts African Extinction Vegetable2020 •